MabCure IncOver The Counter Market:MBCI
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range
- 52 Week Range
- Volume1,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MBCI |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
MabCure Inc | 780.0 | 0.0x | --- |
Cardax Inc | 80.0 | 0.0x | --- |
Integrative Health Technologies Inc | 40.0 | 0.0x | --- |
Viropro Inc | 1.2K | 0.0x | --- |
AVAX Technologies Inc | 1.4K | 0.0x | --- |
Comera Life Sciences Holdings Inc | 6.2K | 0.0x | --- |
Company Information
Mabcure Inc. was in the business of seeking cancer cures. The Company has ceased its operations.
Contact Information
- Headquarters
- 275 Palm Beach Drive, Jolly Harbour PO Box 203BROOKLYN, Antigua and Barbuda 89701-4201
- Phone
- 268-720-8969
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $780.00 |
|---|---|
Revenue (TTM) | $500.0K |
Shares Outstanding | 781.1M |
MabCure Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.19 |
Book Value | $0.06 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,421.95% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
